In what will provide a significant boost to a biopharma innovator in the field of human hearing, client Otonomy brought in $34.7 million in a recent public offering. The NASDAQ-traded company engaged in the IPO after Procopio patent attorney and PhD scientist Frank Yang performed due diligence, including a review of Otonomy’s intellectual property portfolio.

Learn more about the IPO in Otonomy’s press release.